Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

vatalanib MeSH Supplementary Concept Data 2025


MeSH Supplementary
vatalanib
Unique ID
C404768
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C404768
Entry Term(s)
1-(4-chloroanilino)-(4-pyridylmethyl)phthalazine dihydrochloride
1-(4-chloroanilino)-4-(pyridylmethyl)phthalazine
1-(4-chloroanilino)-4-(pyridylmethyl)phthalazine dihydrochloride
CGP 797870
CGP-797870
PTK 787
PTK-787
PTK787
ZK 222584
ZK 232934
ZK-222584
ZK-232934
ZK222584
ZK232934
Pharm Action
Protein Kinase Inhibitors
Registry Numbers
5DX9U76296
212142-18-2
Related Numbers
212142-18-2
Previous Indexing
*ANGIOGENESIS INHIBITORS (2000)
Heading Mapped to
*Phthalazines
*Pyridines
Frequency
229
Note
blocks vascular endothelial growth factor (VEGF) receptor signaling
Source
Am J Pathol 2000 Feb;156(2):697-707
Date of Entry
2000/03/06
Revision Date
2012/11/05
vatalanib Preferred
PTK 787 Narrower
ZK 232934 Narrower
1-(4-chloroanilino)-(4-pyridylmethyl)phthalazine dihydrochloride Narrower
ZK 222584 Narrower
CGP 797870 Narrower
page delivered in 0.007s